泰益胃錠

Country: Tajwan

Lingwa: Ċiniż

Sors: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Ingredjent attiv:

BENZOCAINE (ETHYL AMINOBENZOATE);;DIASTASE;;NUX VOMICA EXTRACT POWDER;;SCOPOLIA EXTRACT POWDER;;MAGNESIUM CARBONATE;;SWERTIA POWDER;;SODIUM BICARBONATE ( EQ TO SODIUM HYDROGEN CARBONATE)

Disponibbli minn:

武昌貿易有限公司 台北巿南京西路１３號８樓 (04408775)

Għamla farmaċewtika:

錠劑

Kompożizzjoni:

SCOPOLIA EXTRACT POWDER (1208004503) (10%) 3.3333MG; SODIUM BICARBONATE ( EQ TO SODIUM HYDROGEN CARBONATE) (4008000700) 166.667MG; MAGNESIUM CARBONATE (5604002400) 20.000MG; DIASTASE (5616000700) 33.333MG; NUX VOMICA EXTRACT POWDER (5628000321) (10%) 2.000MG; BENZOCAINE (ETHYL AMINOBENZOATE) (8408000200) 33.333MG; SWERTIA POWDER (9200014901) 0.667MG

Unitajiet fil-pakkett:

瓶裝

Klassi:

製　劑

Tip ta 'preskrizzjoni:

須經醫師指示使用

Manifatturat minn:

YOSHIDA PHARM. IND. CO. LTD. 8-11 HIGASHISAKAECHO YOSHIDAMACHI NIIGATA 959-02 JAPAN2-5-1 NISHIKOBARIDAI NIIGATA,JAPAN JP

Indikazzjonijiet terapewtiċi:

胃痛、胃酸過多、胃炎、消化不良、腹痛

Sommarju tal-prodott:

註銷日期: 1986/08/12; 註銷理由: 移轉（申請商）; 有效日期: 1986/09/17; 英文品名: DYROMIN A TABLETS

L-istatus ta 'awtorizzazzjoni:

已註銷

Data ta 'l-awtorizzazzjoni:

1981-09-17